Management of breakthrough disease in patients with multiple sclerosis: when an increasing of Interferon beta dose should be effective?

被引:0
|
作者
Luca Prosperini
Giovanna Borriello
Laura De Giglio
Laura Leonardi
Valeria Barletta
Carlo Pozzilli
机构
[1] S. Andrea Hospital,Multiple Sclerosis Centre, Dept. of Neurology and Psychiatry
[2] Sapienza University,undefined
来源
BMC Neurology | / 11卷
关键词
Expand Disability Status Scale; Expand Disability Status Scale Score; Annualise Relapse Rate; Rebif; Disability Progression;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Measurement of neutralizing antibodies to interferon beta in patients with multiple sclerosis
    Florian Deisenhammer
    Huub Schellekens
    Antonio Bertolotto
    Journal of Neurology, 2004, 251 : ii31 - ii39
  • [22] Commentary on neutralizing antibodies to interferon beta in patients with multiple sclerosis
    Whitaker, JN
    ARCHIVES OF NEUROLOGY, 2001, 58 (08) : 1301 - 1301
  • [23] Depression in patients with multiple sclerosis in view of treatment with interferon beta
    Pokryzko-Dragan, A.
    Bilinska, M.
    Gruszka, E.
    Kipinski, L.
    Kotkowska, A.
    Majewska, K.
    Malinowska, M.
    MULTIPLE SCLEROSIS, 2007, 13 : S48 - S49
  • [24] Depression in interferon-beta treated multiple sclerosis patients
    Guedes, R.
    Peixoto de Sousa, C.
    Curral, R.
    Silveira, C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S466 - S467
  • [25] Treatment with interferon beta-1 in patients with multiple sclerosis
    Sonka, Karel
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2013, 76 : 5 - 5
  • [26] Polyneuropathy associated with interferon beta treatment in patients with multiple sclerosis
    Ekstein, D
    Linetsky, E
    Abramsky, O
    Karussis, D
    NEUROLOGY, 2005, 64 (06) : A374 - A374
  • [27] Polyneuropathy associated with interferon beta treatment in patients with multiple sclerosis
    Ekstein, D
    Linetsky, E
    Abramsky, O
    Karussis, D
    NEUROLOGY, 2005, 65 (03) : 456 - 458
  • [28] Measurement of neutralizing antibodies to interferon beta in patients with multiple sclerosis
    Deisenhammer, F
    Schellekens, H
    Bertolotto, A
    JOURNAL OF NEUROLOGY, 2004, 251 (Suppl 2) : 31 - 39
  • [29] Antiviral activity of interferon beta treatment in multiple sclerosis patients
    Garcia-Montojo, Marta
    Alvarez-Lafuente, Roberto
    Doniinguez-Mozo, Maria Inniaculada
    De las Heras, Virginia
    Bartolome, Francisco Manuel
    Arroyo, Rafael
    MULTIPLE SCLEROSIS, 2008, 14 : S65 - S66
  • [30] Interferon beta affect on lesions' size in patients with multiple sclerosis
    Di Rezze, S
    Gupta, S
    Durastanti, V
    Finamore, L
    Gasperini, C
    Bastianello, S
    Millefiorini, E
    Pozzilli, C
    Bagnato, F
    NEUROLOGY, 2004, 62 (07) : A490 - A490